300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
CleanTech
Retail
Film
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Manufacturing
Real Estate
Sporting Goods
Social Media
FinTech
Financial Services
Finance
Franchise
Non Profit
Internet
Mobile Advertising
Digital Media
Android
Proptech
Impact
Enterprise
Sustainability
Hardware
Biotech
Transportation
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Japan
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Armenia
Colombia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Botswana
Moldova
Seychelles
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ireland
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Rwanda
Portugal
El Salvador
Senegal
Tanzania
Sierra Leone
United States
India
Germany
Middle East
Indonesia
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Europe
Qatar
Angola
Cyprus
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bangladesh
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Liechtenstein
Honduras
Iceland
Cambodia
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Life Science Startup Investors in Spain (October 2026)

The most active venture capital funds and angel investors investing in Spain Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Spain Life Science startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Centre for the Development of Industrial Technology (CDTI)
VC Fund
9 Spain, United States, United Kingdom Grant, Venture - Series Unknown, Seed Biotechnology, Health Care, Software $167k–$22M
Bullnet Capital
VC Fund
8 Spain, United States, Mexico Seed, Series A Software, Manufacturing, Information Technology $567k–$11M
Capital Cell
VC Fund
7 Spain, France, United States Equity Crowdfunding, Seed, Venture - Series Unknown Health Care, Biotechnology, Medical $138k–$3.9M
BeAble Capital
VC Fund
7 Spain, Italy Pre-Seed, Seed Biotechnology, Manufacturing, Software $132k–$1.2M
Invivo Capital Partners
VC Fund
6 Spain, France, Belgium Seed, Series A, Venture - Series Unknown Biotechnology, Pharmaceutical, Health Care $1.6M–$70M
Inveready
VC Fund
5 Spain, United States, France Seed, Venture - Series Unknown, Debt Financing Software, Biotechnology, Health Care $400k–$6.5M
Asabys Partners
VC Fund
5 Spain, France, Belgium Series A, Series B, Seed Health Care, Biotechnology, Medical Device $1.3M–$135M
ENISA
VC Fund
4 Spain, United States, France Debt Financing, Seed, Pre-Seed Software, Health Care, Artificial Intelligence $68k–$1.6M
Nara Capital
VC Fund
4 Spain Seed, Venture - Series Unknown, Series A Life Science, Biotechnology, Medical $394k–$7.3M
CDTI Innovación's INNVIERTE program
VC Fund
4 Spain, Panama, Switzerland Venture - Series Unknown, Seed, Grant Biotechnology, Health Care, Medical $260k–$16M
INNVIERTE ECONOMIA SOSTENIBLE SICC SME SA
VC Fund
3 Spain Series A, Venture - Series Unknown, Grant Semiconductor, Life Science, Manufacturing $390k–$3.2M
Ysios Capital
VC Fund
3 Spain, United States, Switzerland Series A, Series B, Series C Biotechnology, Health Care, Medical $3.8M–$135M
Alta Life Sciences
VC Fund
3 Spain, United States Series A, Venture - Series Unknown, Series B Biotechnology, Health Care, Therapeutics $3M–$87M
Fund+
VC Fund
3 Belgium, United States, Spain Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $11M–$401M
BStartup - Banc Sabadell
VC Fund
2 Spain, Mexico, United States Seed, Venture - Series Unknown, Pre-Seed Software, Artificial Intelligence, Information Technology $110k–$5.6M
Xesgalicia
VC Fund
2 Spain, Portugal Seed, Venture - Series Unknown, Pre-Seed Software, Biotechnology, B2B $289k–$5.9M
CDTI
VC Fund
2 Spain, United States, Mexico Venture - Series Unknown, Seed Software, Information Technology, Health Care $314k–$5.4M
Criteria Bio Ventures
VC Fund
2 Spain, United Kingdom, France Series A, Seed, Pre-Seed Biotechnology, Health Care, Life Science $3.5M–$83M
BoxOne Ventures
VC Fund
2 Canada, United States, United Kingdom Seed, Pre-Seed, Series A Biotechnology, Health Care, Software $281k–$115M
Amadeus Capital Partners
VC Fund
2 United Kingdom, United States, Spain Seed, Series A, Series B Software, Artificial Intelligence, Information Technology $800k–$56M
Amino Collective
VC Fund
2 United States, United Kingdom, Germany Seed, Series A, Pre-Seed Biotechnology, Health Care, Artificial Intelligence $125k–$37M
European Investment Bank
VC Fund
2 France, Germany, Spain Debt Financing, Post-IPO Debt, Venture - Series Unknown Biotechnology, Energy, Health Care $8.7M–$587M
Speedinvest
VC Fund
2 United Kingdom, Germany, Austria Seed, Series A, Pre-Seed Software, FinTech, Artificial Intelligence $411k–$33M
Demium Capital
VC Fund
2 Spain, Portugal, Poland Pre-Seed, Seed, Series A Software, Information Technology, Artificial Intelligence $110k–$3.1M
Charme Capital Partners
VC Fund
2 Italy, Spain, United States Private Equity, Series A, Venture - Series Unknown Health Care, Manufacturing, Medical $5.6M–$20M
Criteria Venture Tech
VC Fund
2 Spain, United States, United Kingdom Seed, Venture - Series Unknown, Series A Software, Biotechnology, E-Commerce $303k–$21M
Josep Carreras Leukaemia Research Institute
VC Fund
2 Spain Seed Life Science, Biotechnology $3.6M–$7.3M
Monte Carlo Capital
VC Fund
2 United States, United Kingdom, Switzerland Seed, Series A, Venture - Series Unknown Software, Artificial Intelligence, FinTech $375k–$100M
Grow Venture Partners
VC Fund
2 Spain, Sweden Seed, Pre-Seed, Venture - Series Unknown Health Care, Software, Biotechnology $106k–$9.5M
Inveniam
VC Fund
2 Spain Seed, Grant Biopharma, Health Care, Life Science $568k–$1.1M
Clave Capital
VC Fund
2 Spain, Chile, Switzerland Seed, Venture - Series Unknown, Series A Biotechnology, Software, Health Care $462k–$21M
Talis Capital
VC Fund
2 United Kingdom, United States, Germany Series A, Seed, Series B Software, Information Technology, E-Commerce $1M–$30M
Arman Anatürk
Angel
1 Spain, Israel, Germany Seed, Pre-Seed Biotechnology, Food and Beverage, Wellness $2M–$8.4M
David Brandes
Angel
1 Spain Seed Wellness, Life Science, Biotechnology
Novartis Venture Fund
VC Fund
1 United States, Switzerland, United Kingdom Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $5.1M–$107M
Banc Sabadell and the Institut Català de Finances (ICF)
VC Fund
1 Spain, Switzerland Seed, Debt Financing, Pre-Seed Wellness, Health Care, Medical Device $191k–$425M
Clave Mayor
VC Fund
1 Spain, Germany, United States Seed, Series A Software, Biotechnology, Medical $258k–$8.9M
Nina Capital
VC Fund
1 United States, United Kingdom, Germany Seed, Pre-Seed, Series A Health Care, Artificial Intelligence, Software $529k–$21M
Alma Mundi Ventures
VC Fund
1 Spain, United States, United Kingdom Series A, Seed Software, Insurance, InsurTech
Debiopharm Innovation Fund
VC Fund
1 Switzerland, United States, France Series A, Seed, Pre-Seed Health Care, Biotechnology, Software $943k–$25M
Milad Alucozai
Angel
1 United States, Canada, United Kingdom Seed, Series A, Pre-Seed Biotechnology, Health Care, Medical
Fides Capital
VC Fund
1 Spain Seed, Pre-Seed, Series A Software, Automotive, Telecommunications
BAGi
VC Fund
1 Spain, Norway, Switzerland Seed, Angel Internet, Health Care, Information Technology
Alantra
VC Fund
1 Spain, France, Sweden Private Equity, Debt Financing, Series B Financial Services, Manufacturing, Information Technology
SeedBlink
VC Fund
1 Romania, United States, United Kingdom Seed, Pre-Seed, Series A Software, Information Technology, SaaS
Ship2B Ventures
VC Fund
1 Spain, Germany, United Kingdom Seed, Series A Health Care, Biotechnology, Agriculture
Arnaldo Marziali
Angel
1 Spain Pre-Seed Big Data, Software, Life Science
General Inception
VC Fund
1 United States, Spain, France Seed, Pre-Seed Biotechnology, Life Science, Genetics
Sofinnova Partners
VC Fund
1 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical
Pontifax
VC Fund
1 United States, Israel, France Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $6.3M–$128M
Access all 173 investors in Spain Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Centre for the Development of Industrial Technology (CDTI)
VC Fund · Madrid, Madrid, Spain · 9 investments in Spain Life Science startups, 25 in the past 12 months

The Center for Industrial Technological Development (CDTI) is a public corporation under the Ministry of Economy and Competitiveness, which promotes innovation and technological development of Spanish companies. Is the entity which channels requests for funding and support to projects I + D + i of Spanish companies in the national andinternational levels. The CDTI has a staff of more than 300 people formed three quarters of engineers and graduates. Although the bulk of the infrastructure of the CDTI is located in Madrid, the Centre offers Spanish companies a strategic network of offices and representatives abroad (Japan -SBTO (Spain Business and Technology Office) - Belgium -SOST (Spain Office of Science and Technology) and Permanent Secretariat Eureka-, Brazil -FINEP (Financier of Studies and Projects) -, Korea, Chile, Morocco, China, India, Mexico and USA) to support them in their technological activities of type int .

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Grant, Venture - Series Unknown, Seed
  • Geography: Spain, United States, United Kingdom

Investor stats

  • Total investments: 224
  • Round size: Seed $576k–$5.8M; Grant $167k–$15M; Venture - Series Unknown $846k–$22M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • MOA — MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
  • Anaconda BioMed — Anaconda Biomed, headquartered in Barcelona, Spain, is among the world's most innovative early stage medical technology companies. The company was founded by Dr. Ofir Arad and Dr. Marc Ribó in 2015, and is developing the ANCD BRAIN™, a novel 3rd Generation Stented Aspiration Thrombectomy System for the treatment of Acute Ischemic Stroke (AIS).
  • Connecta Therapeutics — Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of the central nervous system. It focuses on the development of a first-in-class drug for the treatment of fragile X syndrome.
Show all investments...

Bullnet Capital
VC Fund · Pozuelo De Alarcón, Madrid, Spain · 8 investments in Spain Life Science startups

Independent Venture Capital Firm specialized in high technology Spanish start-ups. Helping tech entrepreneurs during the early stages of their company to build successful businesses

Show more...

Investment focus

  • Industry: Software, Manufacturing, Information Technology
  • Stage:Seed, Series A
  • Geography: Spain, United States, Mexico

Investor stats

  • Total investments: 68
  • Round size: Seed $1M–$3.2M; Series A $567k–$11M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: Likely still investing — raised $87M in 2023

Portfolio highlights

  • FlexiiC — Reinventing the world of electronics with a revolutionary organic and flexible technology that enables a new generation of sensors and logic based on solution deposited functional inks at a low temperature, on low-cost substrates to make organic integrated circuits. Products and services FlexiiC presents design modeling services including Application Specific Integrated Circuits (ASIC) and Process ... Read more
  • Bioherent — Photonic biosensors for drug allergy diagnosis
  • Impetux Optics — Impetux is a worldwide key manufacturer and supplier of turnkey optical tweezers systems designed for mechanobiology studies in living cells and 3D tissues.
Show all investments...

Capital Cell
VC Fund · Barcelona, Catalonia, Spain · 7 investments in Spain Life Science startups

Capital Cell is a crowdinvesting platform for biotech and life sciences companies. Mixing VC, business angels, accredited investors, and the power of the crowd, the company is building a global meeting point for companies and researchers working, fostering, and financing tomorrow’s medical science.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Equity Crowdfunding, Seed, Venture - Series Unknown
  • Geography: Spain, France, United States

Investor stats

  • Total investments: 53
  • Round size: Seed $392k–$1.9M; Equity Crowdfunding $138k–$1.5M; Venture - Series Unknown $617k–$3.9M
  • Lead/follow: 26% lead, 74% follow

Portfolio highlights

  • AbTx — Antibody for Therapy
  • DYNAMICS VR — Dynamics VR provides rehab software for clinics to tackle musculoskeletal pain and movement impairments caused by brain trauma.
  • EVis Bioscience — EVis Bioscience develops innovative gene delivery systems for targeted and personalized medicine. This includes extracellular vesicles, synthetic lipid nanoparticles, and their hybrids.
Show all investments...

BeAble Capital
VC Fund · Madrid, Madrid, Spain · 7 investments in Spain Life Science startups

BeAble Capital is a Science Equity Fund, therefore it is a pre-seed, seed and early stage venture capital management company specialized in the identification, valuation, launch and development of technologies in the sectors of advanced materials (nanotechnology and biotechnology), photonics, micro and nano electronics and Information andcommunications technologies (ICT) platforms.It acts as the link between scientific, entrepreneurial and investing worlds to promote the transfer of technology, the creation and the development of technology-based companies (start-ups) from private equity. The company is focused on strong intelectual property and long R&D background projects. Their work provide value at different stages of development by offering support in strategic points such as the identification of technologies, valuation, transfer, companies creation, fundraising, marketing, internationalization and administrative and managerial expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Software
  • Stage:Pre-Seed, Seed
  • Geography: Spain, Italy

Investor stats

  • Total investments: 70
  • Round size: Seed $158k–$1.2M; Pre-Seed $132k–$514k
  • Lead/follow: 83% lead, 17% follow
  • Last fund: May invest from a new fund soon — raised $39M in 2016

Portfolio highlights

  • Molecular Gate — Transformative Anti-Counterfeiting Technology. Multifunctional Level 1 Anti-Counterfeit Solutions: See-through Polargram and Reflective Polargram
  • Bioinspired Materials — Bioinspired Materials is a Biotech-based entrepreneurship project with the participation of the Universitat Pompeu Fabra. The company develops wastewater valorization that produces biological products of high value in the market. BIOM was founded in 2019 and is based in Barcelona, Spain.
  • Ars Magna Semiconductors — Ars Magna Semiconductors develops semiconductor chips designed for decentralized artificial intelligence applications. The company's technology operates with low energy consumption, real-time processing, and enhanced data privacy by reducing the number of operations and hardware requirements. Their chips address the global semiconductorshortage while enabling more efficient AI processing with reduced computational overhead.
Show all investments...

Invivo Capital Partners
VC Fund · Barcelona, Catalonia, Spain · 6 investments in Spain Life Science startups

Invivo Capital is a team of knowledgeable professionals with the scientific, technical, and financial know-how required to analyze and make investments that provide value to the invested company. They also have a network of contacts and key strategic relationships in the health ecosystem.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Health Care
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Spain, France, Belgium

Investor stats

  • Total investments: 35
  • Round size: Seed $1.6M–$13M; Series A $2.2M–$70M; Venture - Series Unknown $3.3M–$8.9M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: May invest from a new fund soon — raised $44M in 2019

Portfolio highlights

  • Signadori Bio — Signadori Bio is the next-generation cellular immunotherapy for cancer cure.This has culminated in the creation of a groundbreaking biotech venture in the cell and gene space that is set to advance innovative approaches in oncology.
  • ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
  • Telum Therapeutics — Telum Therapeutics is a biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages.
Show all investments...

Inveready
VC Fund · Barcelona, Catalonia, Spain · 5 investments in Spain Life Science startups, 11 in the past 12 months

Inveready is a leading Spanish financial services firm focused on investment solutions and wealth management.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Venture - Series Unknown, Debt Financing
  • Geography: Spain, United States, France

Investor stats

  • Total investments: 280
  • Round size: Seed $400k–$4.7M; Debt Financing $1.2M–$6.5M; Venture - Series Unknown $594k–$5.7M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: Likely still investing — raised $63M in 2024

Portfolio highlights

  • Mirai — Mirai offers solutions for balance sheet management, financial risk, and regulatory compliance.
  • Inventia Kinetics — Inventia Kinetics specializes in the design, analysis, and manufacture of equipment and assembly tools for electronics sector.
  • Connecta Therapeutics — Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of the central nervous system. It focuses on the development of a first-in-class drug for the treatment of fragile X syndrome.
Show all investments...

Asabys Partners
VC Fund · Barcelona, Catalonia, Spain · 5 investments in Spain Life Science startups

Fostering breakthrough innovation in healthcareAsabys is an investment firm based in Barcelona, investing in healthcare and life-sciences innovation. PORTFOLIO TEAM Impact We want to push the boundaries of science and medicine improving patient's life Disruptive We look for highly innovative and transformative technologies Hands-on We consider ourselves partners and collaborators to our portfolio

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Series B, Seed
  • Geography: Spain, France, Belgium

Investor stats

  • Total investments: 40
  • Round size: Seed $1.3M–$17M; Series A $7M–$57M; Series B $18M–$135M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: Likely still investing — raised $117M in 2022

Portfolio highlights

  • iPremom — iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early detection and prediction of pregnancy complications, particularly preeclampsia.
  • Anaconda BioMed — Anaconda Biomed, headquartered in Barcelona, Spain, is among the world's most innovative early stage medical technology companies. The company was founded by Dr. Ofir Arad and Dr. Marc Ribó in 2015, and is developing the ANCD BRAIN™, a novel 3rd Generation Stented Aspiration Thrombectomy System for the treatment of Acute Ischemic Stroke (AIS).
  • Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
Show all investments...

ENISA
VC Fund · Madrid, Madrid, Spain · 4 investments in Spain Life Science startups, 22 in the past 12 months

ENISA is a public company under the Ministry of Industry, Energy and Tourism, through the Directorate General of Industry and Small and medium-sized enterprises which, since 1982, actively participates in the financing of viable and innovative business projects.

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Debt Financing, Seed, Pre-Seed
  • Geography: Spain, United States, France

Investor stats

  • Total investments: 240
  • Round size: Seed $79k–$1.6M; Pre-Seed $165k–$1.2M; Debt Financing $68k–$489k
  • Lead/follow: 43% lead, 57% follow

Portfolio highlights

  • Naturr — Nature, which seeks to connect small-scale artisanal food producers from rural areas with urban consumers. Nature platform could serve as an important bridge for promoting local and sustainable food systems, benefiting both rural producers and urban consumers i
  • Pekata — Pekata offers technological solution that allows employee to customize hamper based on personal tastes, dietary restrictions.
  • DARWIN Biomed — Biomedical Engineering
Show all investments...

Nara Capital
VC Fund · Barcelona, Catalonia, Spain · 4 investments in Spain Life Science startups

As asset managers, we invest on behalf of third parties. Our fear of losing their money is greater than the fear of losing an opportunity. Our investment style consists of value orientation, specialization and trust, applying our investment criteria in a disciplined way. We invest to transform the companies into industry leaders. With a hands-onapproach, Nara invests in assets enhancing its value with a long-term view. We are a highly experienced team with the patience and tenacity required to see deals through, committing our own money. We create value in a sustainable way, investing in a responsible way to generate a positive impact on the community. We analyze each investment in detail in order to create shared value for our investors, partners, customers, suppliers and workers.

Show more...

Investment focus

  • Industry: Life Science, Biotechnology, Medical
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: Spain

Investor stats

  • Total investments: 10
  • Round size: Seed $394k–$7.3M; Venture - Series Unknown $1.9M–$3.3M
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • Aortyx — With a focus on aortic dissection, Aortyx has developed a bioresorbable endovascular patch designed to seal the entry tear, delivered through a proprietary dual-steerable catheter.
  • MiMARK — MiMARK specializes in developing in vitro diagnostic solutions to improve the management of gynecological malignancies. The company envisions the gynecological fluid as the next step in liquid biopsy in gynecology. MiMARK 's first objective is to improve endometrial cancer diagnosis.
  • Neboda — We are an indoor vertical farming company that combines combines a scientific approach and an industrial automation background.
Show all investments...

CDTI Innovación's INNVIERTE program
VC Fund · Madrid, Madrid, Spain · 4 investments in Spain Life Science startups, 16 in the past 12 months

CDTI Innovación's INNVIERTE program is part of the Spanish Science, Technology, and Innovation Strategy. This Strategy is one of the cornerstones around which the Government's R&D&I strategy for the upcoming years is built. It outlines the goals, changes, and actions that must be implemented across the R&D&I sector inorder to maximize its growth and effect.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Venture - Series Unknown, Seed, Grant
  • Geography: Spain, Panama, Switzerland

Investor stats

  • Total investments: 57
  • Round size: Seed $266k–$6.4M; Grant $260k–$1.1M; Venture - Series Unknown $330k–$16M
  • Lead/follow: 37% lead, 63% follow

Portfolio highlights

  • MOA — MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
  • Flomics — Flomics uses circulating transcriptomic analysis to provide novel non-invasive, fast and affordable diagnostics for complex diseases.
  • Accexible — Accexible focuses on the development of technology that extracts acoustic characteristics from the speech of a person who gives us clues to his health and well-being. Accexible identifies vocal biomarkers, specific characteristics of the voice that indicate various health conditions, for the diagnosis and monitoring of diseases
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
INNVIERTE ECONOMIA SOSTENIBLE SICC SME SA
VC Fund · 3 investments in Spain Life Science startups

Investment focus

  • Industry: Semiconductor, Life Science, Manufacturing
  • Stage:Series A, Venture - Series Unknown, Grant
  • Geography: Spain

Investor stats

  • Total investments: 13
  • Round size: Series A $390k–$1.4M; Venture - Series Unknown $1.6M–$3.2M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • Basquevolt — Basquevolt is a leader in solid state battery technology.
  • FYLA — FYLA designs ultrafast fiber lasers, combining precision engineering and quality. Discover supercontinuum and femtosecond laser solutions.
  • A4CELL — A4CELL is a company that develops SPAchip (suspended planar-array chips) that help monitor living single cells. They offer SPAchips, as well as the CytoCHECK SPAchip and the CytoCHECK SPAchip. The company's goal is to increase the accuracy and quality of cell study data in order to better understand disease behavior.
Show all investments...

Ysios Capital
VC Fund · San Sebastian, Pais Vasco, Spain · 3 investments in Spain Life Science startups

Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: Spain, United States, Switzerland

Investor stats

  • Total investments: 86
  • Round size: Series A $3.8M–$65M; Series B $17M–$135M; Series C $29M–$83M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: May invest from a new fund soon — raised $246M in 2020

Portfolio highlights

  • AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
  • Inbiomotion — Inbiomotion is focused on the development and commercialization of a biomarker that predicts metastasis to improve patients' quality of life by personalizing the adjuvant treatment of early stage breast cancer. Founded in 2010 by Dr. Roger Gomis, it is a spin-off of IRB Barcelona and ICREA research institutions.Inbiomotion's uniquediagnostic assay is based on a highly selective single gene biomarker. Data generated thus far suggests such biomarker can identify early stage breast cancer patients that will benefit from bisphosphonate adjuvant treatment improving their overall and invasive disease free survival. It can further predict at an early stage a patient's risk of metastases relapse from primary tumors. The selectivity of the lead biomarker has the potential to advance the clinical standard of care using personalized medicine.
  • Anaconda BioMed — Anaconda Biomed, headquartered in Barcelona, Spain, is among the world's most innovative early stage medical technology companies. The company was founded by Dr. Ofir Arad and Dr. Marc Ribó in 2015, and is developing the ANCD BRAIN™, a novel 3rd Generation Stented Aspiration Thrombectomy System for the treatment of Acute Ischemic Stroke (AIS).
Show all investments...

Alta Life Sciences
VC Fund · Barcelona, Catalonia, Spain · 3 investments in Spain Life Science startups

Alta Life Sciences is a leading multistage venture capital investment firm. Alta LS will invest in companies at all stages of development: from seed financing through commercial growth. Alta LS invests in all areas of life sciences including biotechnology, medical devices, diagnostics, genomics and digital health.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Venture - Series Unknown, Series B
  • Geography: Spain, United States

Investor stats

  • Total investments: 18
  • Round size: Series A $3M–$34M; Series B $13M–$87M; Venture - Series Unknown $3.3M–$14M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
  • Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
  • Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
Show all investments...

Fund+
VC Fund · Leuven, Vlaams-Brabant, Belgium · 3 investments in Spain Life Science startups

Fund+ is a venture capital firm that invests in companies operating in the diagnostics, therapeutics, medical devices, and life science sectors. The firm wants to create sustainable shareholders' value, contribute to the development of a leadership position in the life sciences sector, and generate a tangible, beneficial societal impact.Fund+ was established in 2015 and is based in Leuven, Belgium.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: Belgium, United States, Spain

Investor stats

  • Total investments: 35
  • Round size: Series A $12M–$47M; Series B $22M–$125M; Series C $11M–$401M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
  • Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
  • TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Show all investments...

BStartup - Banc Sabadell
VC Fund · Sant Cugat Del Vallès, Catalonia, Spain · 2 investments in Spain Life Science startups

A Banc Sabadell initiative to support young companies in developing their projects. Bstartup is designed to support entrepreneurs so their projects can be developed with maximum guarantees of success. - Investment and growth - Specialized products and branches - Collaborative innovation

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Venture - Series Unknown, Pre-Seed
  • Geography: Spain, Mexico, United States

Investor stats

  • Total investments: 91
  • Round size: Seed $110k–$2M; Pre-Seed $110k–$900k; Venture - Series Unknown $121k–$5.6M
  • Lead/follow: 48% lead, 52% follow

Portfolio highlights

  • TietAI — TietAI is the agentic integration layer for hospitals, payers and digital health, unifying HL7, FHIR, X12 and DICOM into one governed plane.
  • Energiot — Energiot specialized engineering service in energy harvesting, self-powered devices, wireless sensor networks.
  • Floatech — Discover Floatech: Boosting lithium-ion batteries with sustainable, high-performance silicon anodes. Explore our innovative technology.
Show all investments...

Xesgalicia
VC Fund · Santiago De Compostela, Galicia, Spain · 2 investments in Spain Life Science startups

XesGalicia is a Galician Venture Capital Management firm. It finances company development through the temporary acquisition of minority shares of the capital of unquoted companies.

Show more...

Investment focus

  • Industry: Software, Biotechnology, B2B
  • Stage:Seed, Venture - Series Unknown, Pre-Seed
  • Geography: Spain, Portugal

Investor stats

  • Total investments: 34
  • Round size: Seed $289k–$5.9M; Pre-Seed $464k–$2.5M; Venture - Series Unknown $904k–$5.5M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Kreios Space — Kreios Space is developing an electric propulsion system to revolutionize the satellite industry. With this technology we enable orbital keeping in VLEO (Very Low Earth Orbits) thanks to renewable energy. We make space applications easier.
  • VigSec-Drone — VigSec-Drone is a high-performance security and surveillance designed to deliver real-time situational awareness.
  • Iteria Biopharma — PROFESSIONAL TEAM User can utilize his smartphone to pay for a wide range of services or any CONSULTATION User can utilize his smartphone to pay for a wide range of services or any TREATMENT User can utilize his smartphone to pay for a wide range of services or any First-in-class NCEs addressed to modulate challenging
Show all investments...

CDTI
VC Fund · Ventura, California, United States · 2 investments in Spain Life Science startups

Developing combustion engine catalyst and coating technology to reduce emissions and improve fuel efficiency for clean energy production.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Venture - Series Unknown, Seed
  • Geography: Spain, United States, Mexico

Investor stats

  • Total investments: 37
  • Round size: Seed $314k–$2.8M; Venture - Series Unknown $765k–$5.4M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
  • PLD Space — PLD Space is a spanish innovative start-up company is to provide low cost and high reliability access to space. PLD Space offers suborbital and orbital launch services to its clients.
  • Atlas Molecular Pharma — Latest News Your browser does not support the video tag.
Show all investments...

Criteria Bio Ventures
VC Fund · Barcelona, Catalonia, Spain · 2 investments in Spain Life Science startups

Supporting life-changing therapies through long-term strategic partnerships

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Series A, Seed, Pre-Seed
  • Geography: Spain, United Kingdom, France

Investor stats

  • Total investments: 7
  • Round size: Pre-Seed $3.5M–$3.5M; Series A $29M–$83M
  • Lead/follow: 43% lead, 57% follow

Portfolio highlights

  • NRG Therapeutics — energizing drug discovery in neurodegenerative diseases.
  • Adaptam Therapeutics — Pioneering cancer immunotherapies targeting the immunosuppressive myeloid tumor microenvironment for the treatment of solid tumors.
  • Cytospire Therapeutics — Cytospire Therapeutics is bringing forward a portfolio of next generation immune cell engagers.
Show all investments...

BoxOne Ventures
VC Fund · Montréal, Quebec, Canada · 2 investments in Spain Life Science startups

BoxOne Ventures is a privately held investment firm that focuses on early-stage companies across the most impactful, interesting and fast-changing sectors.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Canada, United States, United Kingdom

Investor stats

  • Total investments: 69
  • Round size: Seed $1.3M–$9.5M; Pre-Seed $281k–$2M; Series A $744k–$115M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Dispersa — Harnessing the power of microbe-derived natural solutions to decarbonize the chemicals industry.
  • Opalia — Opalia is introducing a new era of dairy: functional, delicious, and sustainable dairy made from mammary cells.
  • Thred — Thred is the first B2B Intent platform designed for AI. Act on accounts researching in ChatGPT, Gemini, and Claude.
Show all investments...

Amadeus Capital Partners
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 2 investments in Spain Life Science startups, 7 in the past 12 months

Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Spain

Investor stats

  • Total investments: 277
  • Round size: Seed $800k–$9.2M; Series A $2.6M–$30M; Series B $7.2M–$56M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: Likely still investing — raised $85M in 2023

Portfolio highlights

  • iPremom — iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early detection and prediction of pregnancy complications, particularly preeclampsia.
  • Slamcore — Positioning, mapping and perception | State-of-the-art visual SLAM turns sensor data into actionable, spatial understanding for your vehicles.
  • Respiro Diagnostics — Respiro is harnessing insights from the breath to detect lung cancer earlier, non-invasively, and without scans or radiation. Built for use in everyday care settings.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Amino Collective
VC Fund · Berlin, Berlin, Germany · 2 investments in Spain Life Science startups, 6 in the past 12 months

Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 46
  • Round size: Seed $2.4M–$14M; Pre-Seed $125k–$7.8M; Series A $12M–$37M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Calibre — Calibre uses causal AI in conjunction with clinical expertise to help people understand what is truly influencing their health and how to modify it.
  • Modern Relay — Modern Relay provides context graph for enterprise AI.
  • Tandem Health — Focus on providing care, while Tandem helps you easily write medical notes directly after the patient consultation.
Show all investments...

European Investment Bank
VC Fund · Luxembourg, Luxembourg, Luxembourg · 2 investments in Spain Life Science startups

The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.

Show more...

Investment focus

  • Industry: Biotechnology, Energy, Health Care
  • Stage:Debt Financing, Post-IPO Debt, Venture - Series Unknown
  • Geography: France, Germany, Spain

Investor stats

  • Total investments: 595
  • Round size: Post-IPO Debt $18M–$587M; Debt Financing $16M–$355M; Venture - Series Unknown $8.7M–$90M
  • Lead/follow: 83% lead, 17% follow

Portfolio highlights

  • VaxThera — VaxThera develops and produces vaccines to prevents and treats diseases.
  • Santander Brasil — Banco Santander in Brazil, its largest division in Latin America and one of the world's most important, accounting for 50%.
  • Reactive Technologies — Reactive Technologies we are committed to enabling a more intelligent use of energy, for the largest and most complex business to the smallest household. Our aim is to develop new technologies that will positively assist the energy industry to deliver cleaner, greener and more affordable energy, through more efficient and effective energymanagement and control. Through our innovative, cloud-based solution for Corporate customers – Tradenergy® – we have begun this process and with our pipeline of ground breaking new technologies we intend to continue.
Show all investments...

Speedinvest
VC Fund · Vienna, Wien, Austria · 2 investments in Spain Life Science startups

Speedinvest is a globally active European venture capital firm built on a simple belief: many move more. From six offices across EMEA, our sector-focused investment teams back relentless founders from pre–Seed to Growth with long-term conviction, providing day-one access to our global network of corporate customers, experts, industry leaders, andtop-tier follow-on investors to scale smarter and faster. Building lasting companies like Bitpanda (Austria), Moove (Nigeria), Gigs (U.S.), Tide (UK), ARX Robotics (Germany), Wayflyer (Ireland), GoStudent (Austria), Seqera Labs (Spain), and Cylib (Germany) — together. Big ideas may start with one. But scaling and winning take The Power of More.

Show more...

Investment focus

  • Industry: Software, FinTech, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United Kingdom, Germany, Austria

Investor stats

  • Total investments: 674
  • Round size: Seed $797k–$7.9M; Pre-Seed $411k–$3.8M; Series A $4.1M–$33M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — raised $372M in 2022

Portfolio highlights

  • Findery — Find and leave notes anywhere in the world, discover local knowledge, hidden secrets, and exciting stories. Share your travel knowledge, geoblog, or local news!
  • GAMINSIDE — GAMINSIDE revolutionizes your relationship with your customers. As European full service provider, we deliver the complete package with solutions, services and software for gamified loyalty that is tailor-made and unique to your products, brands and customers. Integrate the best ideas from gamification and customer loyalty in your business areato exceed your commercial targets with GAMINSIDE.
  • Polaron — Material Design. Supercharged with AI.
Show all investments...

Demium Capital
VC Fund · Valencia, Comunidad Valenciana, Spain · 2 investments in Spain Life Science startups

Demium is a talent investment company founded in Spain in 2013 with the aim of supporting the best professionals and helping them to carry out successful projects, always with an eminently digital and technological component. In November 2020, it's asset management company, Demium Capital, started operating with a first €50M fund to invest inmore than 75 early-stage startups per year (pre-seed/seed), becoming the most active venture capital fund in Spain. Startups such as Hannun, Voicemod, Swipcar, Citibox, Singularu or Landbot, among others have been created in the incubator. The company is present in five countries: Spain, Portugal, Poland, Ukraine and Czech Republic

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Pre-Seed, Seed, Series A
  • Geography: Spain, Portugal, Poland

Investor stats

  • Total investments: 85
  • Round size: Seed $113k–$3.1M; Pre-Seed $110k–$574k
  • Lead/follow: 61% lead, 39% follow
  • Last fund: May invest from a new fund soon — raised $59M in 2020

Portfolio highlights

  • Rauda AI — Rauda is an artificial intelligence platform specialized in automating customer service with the best customer experience. Take a quantum leap in productivity, reduce costs and improve customer satisfaction with the power of generative artificial intelligence.
  • Aino — Aino is a location intelligence tool that enables businesses to analyze spatial data in just minutes. Aino saves hundreds of hours on data work for real estate, retail, urban planning, and geo-marketing companies.
  • Orbital Paradigm — Orbital Paradigm builds reusable vehicles that carry cargo to space and bring it back. Dedicated missions, any orbit, on your schedule. Based in Madrid.
Show all investments...

Charme Capital Partners
VC Fund · Milano, Lombardia, Italy · 2 investments in Spain Life Science startups

Charme Capital Partners is a European mid-market private equity fund, supporting management teams and shareholders to achieve transformational change, growth and internationalisationFrom our offices in Milan, London and Madrid we invest in businesses across Europe with an enterprise value of €100m to €500mContinuous interaction with ourinvestor base is key in sourcing new opportunities, testing investment theses and growing portfolio companies

Show more...

Investment focus

  • Industry: Health Care, Manufacturing, Medical
  • Stage:Private Equity, Series A, Venture - Series Unknown
  • Geography: Italy, Spain, United States

Investor stats

  • Total investments: 13
  • Round size: Series A $5.6M–$20M
  • Lead/follow: 23% lead, 77% follow
  • Last fund: May invest from a new fund soon — raised $596M in 2021

Portfolio highlights

  • UNIVERSAE — UNIVERSAE offers vocational training services.
  • Tema Sinergie — Tema Sinergie sviluppa soluzioni avanzate per healthcare, pharma e biotech, integrando tecnologia, precisione, servizio e know-how scientifico.
  • Prism Healthcare — Transforming LivesA leading integrated solutions provider dedicated to transforming lives in the paediatric, home, and long-term care sectors. About Prism Healthcare Group Transforming Lives When health or mobility declines, the...
Show all investments...

Criteria Venture Tech
VC Fund · Barcelona, Catalonia, Spain · 2 investments in Spain Life Science startups

Criteria Venture Tech is the tech VC fund of CriteriaCaixa which invests in B2B SaaS and DeepTech companies in early and growth stages (Seed to Series B) managing more than €300M of AUM.

Show more...

Investment focus

  • Industry: Software, Biotechnology, E-Commerce
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: Spain, United States, United Kingdom

Investor stats

  • Total investments: 172
  • Round size: Seed $303k–$3.8M; Series A $1.9M–$21M; Venture - Series Unknown $561k–$7.3M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: Likely actively investing — fresh fund, raised $140M in 2026

Portfolio highlights

  • 8Layers — 8Layers is an artificial intelligence platform that offers cloud identity threat detection to organizations
  • Barbara — Barbara is the Cybersecure Industrial Edge Platform that enables companies to connect, deploy and scale gateways and edge applications in a few clicks
  • iPronics — iPronics develops the innovative concepts of general-purpose integrated programmable photonic systems.
Show all investments...

Josep Carreras Leukaemia Research Institute
VC Fund · Badalona, Catalonia, Spain · 2 investments in Spain Life Science startups

International research Institute that pursues to study and eradicate Leukaemia, Lymphoma and other Hemopathies.

Show more...

Investment focus

  • Industry: Life Science, Biotechnology
  • Stage:Seed
  • Geography: Spain

Investor stats

  • Total investments: 2
  • Round size: Seed $3.6M–$7.3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • OneChain Immunotherapeutics — CAR-T Immunotherapies against hematological malignancies
Show all investments...

Monte Carlo Capital
VC Fund · Monaco, Bayern, Germany · 2 investments in Spain Life Science startups

Discover Monte Carlo Capital, a leading angel investment firm supporting early-stage startups in technology.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, FinTech
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: United States, United Kingdom, Switzerland

Investor stats

  • Total investments: 67
  • Round size: Seed $375k–$9.3M; Series A $1.3M–$100M; Venture - Series Unknown $2M–$16M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely actively investing — fresh fund, raised $13M in 2025

Portfolio highlights

  • Algorized — Algorized develops advanced technologies for human presence detection using UWB Radar.
  • Ratio — A new way to finance subscription companies without dilution offering flexibility to help you thrive and compete. Put your recurring revenue to work.
  • Scout AI — Scout AI is building the robotic foundation model for defense.
Show all investments...

Grow Venture Partners
VC Fund · Barcelona, Catalonia, Spain · 2 investments in Spain Life Science startups

Venture Capital for Entrepreneurs with seasoned experts and advisors to succed in creating value in a meaningful way. Coaching and Mentoring Ideas People

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: Spain, Sweden

Investor stats

  • Total investments: 27
  • Round size: Seed $549k–$9.5M; Pre-Seed $106k–$2.5M; Venture - Series Unknown $218k–$794k
  • Lead/follow: 59% lead, 41% follow
  • Last fund: Likely actively investing — fresh fund, raised $11M in 2024

Portfolio highlights

  • Tirecat — Tirecat specialized in developing sophisticated tissue regeneration treatments to combat chronic and terminal diseases.
  • X1 Wind — X1 Wind is a disruptive innovative floating wind platform with the potential to make a step change in offshore wind.
  • NSS Water — NSS Water specializes in innovative water purification technology for high-tech sectors such as semiconductors.
Show all investments...

Inveniam
VC Fund · Barcelona, Catalonia, Spain · 2 investments in Spain Life Science startups

Strategic consulting for meaningful innovations in health, sustainability and deep tech.

Show more...

Investment focus

  • Industry: Biopharma, Health Care, Life Science
  • Stage:Seed, Grant
  • Geography: Spain

Investor stats

  • Total investments: 4
  • Round size: Seed $568k–$1.1M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • AtG Therapeutics — At AtG, we develop new drugs and biomarkers to stop cancer metabolic adaptation.
  • NIMBLE Diagnostics — NIMBLE Diagnostics is a technological organization that develops and provides services related to biotechnology research activities.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Clave Capital
VC Fund · Pamplona, Navarra, Spain · 2 investments in Spain Life Science startups

Clave is an investment management company.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: Spain, Chile, Switzerland

Investor stats

  • Total investments: 54
  • Round size: Seed $462k–$4.7M; Series A $3.2M–$21M; Venture - Series Unknown $541k–$7.1M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely still investing — raised $53M in 2023

Portfolio highlights

  • Sensesbit — Sensesbit is a SaaS market research platform focused on sensory intelligence for the food and beverage industry, developed by TasteLab to analyze and predict product market acceptance . The tool integrates advanced statistical analysis, AI for benchmarking, and computer vision tools to manage sensory testing with consumers and trained panels. Learnmore about the platform on the official Sensesbit website.
  • Telum Therapeutics — Telum Therapeutics is a biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages.
  • Connecta Therapeutics — Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of the central nervous system. It focuses on the development of a first-in-class drug for the treatment of fragile X syndrome.
Show all investments...

Talis Capital
VC Fund · London, England, United Kingdom · 2 investments in Spain Life Science startups

We back founders who see the future differently.

Show more...

Investment focus

  • Industry: Software, Information Technology, E-Commerce
  • Stage:Series A, Seed, Series B
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 86
  • Round size: Seed $1M–$15M; Series A $3.1M–$22M; Series B $10M–$30M
  • Lead/follow: 52% lead, 48% follow
  • Last fund: Likely still investing — raised $175M in 2023

Portfolio highlights

  • Monomer Bio — Monomer Bio provides solutions for laboratory automation. We specialize in automating biology research with a focus on cell culture. Automate your cell culture workflows by leveraging the Monomer automation software platform in conjunction with readily-available hardware and instrumentation.
  • Seqera — Seqera Labs is a Barcelona-based business creating solutions for high-performance computing workloads across cloud and clusters. It was founded by the creators of the popular open-source workflow software Nextflow (http://www.nextflow.io).
  • Rubi Laboratories — Rubi Laboratories turns carbon emissions into carbon-negative textiles for the fashion industry, with a proprietary synthetic biology technology.
Show all investments...

Arman Anatürk
Angel · Lausanne, Vaud, Switzerland · 1 investments in Spain Life Science startups

Arman Anatürk is Co-Founder @ FoodHack.

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Wellness
  • Stage:Seed, Pre-Seed
  • Geography: Spain, Israel, Germany

Investor stats

  • Total investments: 5
  • Round size: Seed $2M–$8.4M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Bosque Foods — Kinoko Labs develops the next generation of meat substitutes, starting with whole-cut meat items made from fungal mycelium produced organically. Headquartered in New York.
  • Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
  • Kynda — Keen 4 Greens offers a wide range of vegan products. Founded in 2019, Keen 4 Greens is based in Hamburg, Germany.
Show all investments...

David Brandes
Angel · Berlin, Berlin, Germany · 1 investments in Spain Life Science startups

David Brandes - Managing Director & Co-Founder @ Peace of Meat

Show more...

Investment focus

  • Industry: Wellness, Life Science, Biotechnology
  • Stage:Seed
  • Geography: Spain

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
Show all investments...

Novartis Venture Fund
VC Fund · Basel, Basel-Stadt, Switzerland · 1 investments in Spain Life Science startups

Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 234
  • Round size: Series A $5.1M–$81M; Series B $11M–$107M; Series C $9M–$75M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $200M in 2009

Portfolio highlights

  • Kynexis — Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.
  • Visiogen — Visiogen, Inc. is an ophthalmic medical device company specializing in the development of new vision alternatives for patients with cataracts, with and without presbyopia. As part of this mission, Visiogen created the Synchrony dual optic accommodating *intraocular lens (IOL)* for use in the surgical treatment of these conditions.The device isdesigned to provide patients with near, intermediate and distance vision in a seamless continuum without the need for glasses or contact lenses. To eliminate lens handling during surgery, the Synchrony dual optic IOL is provided in a pre-loaded injector. This patented technology has been approved in Europe with a CE Mark designation and is currently undergoing clinical trials in the United States.
  • Rein Therapeutics — Rein Therapeutics is advancing a novel pipeline of first-in-class medicines to address unmet medical needs in orphan pulmonary and fibrosis indications.
Show all investments...

Banc Sabadell and the Institut Català de Finances (ICF)
VC Fund · 1 investments in Spain Life Science startups

Banc Sabadell and the Institut Català de Finances (ICF)

Show more...

Investment focus

  • Industry: Wellness, Health Care, Medical Device
  • Stage:Seed, Debt Financing, Pre-Seed
  • Geography: Spain, Switzerland

Investor stats

  • Total investments: 7
  • Round size: Seed $764k–$5.2M; Debt Financing $191k–$425M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • Cafler — Your car's personal assistant. Ask for a Cafler now, we move your car for you!
  • Minor Hotels — NH Hotel Group is a consolidated travel and leisure hotel operator. It is one of the top 25 hotel chains in the world and one of the main ones in Europe, currently operating close to 400 hotels with almost 60,000 rooms in 31 countries in Europe, America, and Africa.
  • Impala Terminals — Impala Terminals Group facilitates the global trade of commodities by offering producers and consumers reliable and efficient access to international markets.
Show all investments...

Clave Mayor
VC Fund · Pamplona, Navarra, Spain · 1 investments in Spain Life Science startups

Clave Mayor is a management company of closed investment entities based in Navarra.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: Spain, Germany, United States

Investor stats

  • Total investments: 33
  • Round size: Seed $258k–$5.5M; Series A $2.2M–$8.9M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • MOA — MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
  • Ojer Pharma — Ojer Pharma engages in the research, development, production, and marketing of dermopharmaceutical products in Spain. It develops prescription medicines, cosmetics, and medical devices. The company has developed a vehiculization technology in the form of bioadhesive transparent gels, which acts as a sustained-release matrix of dermatologicalactives, such as lipophilics and hydrophilics.
  • Semi Zabala — Welcome to Semi Zabala, a pioneering semiconductor company dedicated to innovation and excellence. Our mission is to push boundaries and enhance technology, embodying our slogan: beyond the power. Explore our advanced solutions designed for a smarter, more connected future.
Show all investments...

Nina Capital
VC Fund · Barcelona, Catalonia, Spain · 1 investments in Spain Life Science startups, 7 in the past 12 months

We deploy early stage capital to fuel the growth of need-driven health technology companies.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 96
  • Round size: Seed $2M–$6.3M; Pre-Seed $529k–$2.4M; Series A $5M–$21M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: Likely actively investing — fresh fund, raised $52M in 2025

Portfolio highlights

  • Biobase — Biobase is the agentic system for clinical data, closing the gap between clinical data and better healthcare.
  • Ladder Health — Ladder Health offers virtual pediatric therapy and support for early childhood developmental delays, including speech and physical therapy.
  • Woodway Assurance — Woodway Assurance provides EviData, an AI-driven software for automated privacy assurance on de-identified and synthetic datasets.
Show all investments...

Alma Mundi Ventures
VC Fund · Madrid, Madrid, Spain · 1 investments in Spain Life Science startups, 7 in the past 12 months

We back bold and purpose-driven founders.

Show more...

Investment focus

  • Industry: Software, Insurance, InsurTech
  • Stage:Series A, Seed
  • Geography: Spain, United States, United Kingdom

Investor stats

  • Total investments: 108
  • Lead/follow: no public data

Portfolio highlights

  • LAIIER — The best LAIIER of defense against liquid leak-driven damage in buildings and industrial equipment.
  • Ole Insurance Group — Ole Insurance Group focuses on offering protection and well-being products and services through technology. Ole Insurance Group was founded in 2021 and was headquartered in Puerto Rico.
  • Epoch Biodesign — Mellizyme Biotechnology is currently operating in stealth.
Show all investments...

Debiopharm Innovation Fund
VC Fund · Lausanne, Vaud, Switzerland · 1 investments in Spain Life Science startups

Debiopharm invests in Smart Data & Digital Health companies developing technologies that are applicable in the areas of oncology or infectious diseases

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Series A, Seed, Pre-Seed
  • Geography: Switzerland, United States, France

Investor stats

  • Total investments: 37
  • Round size: Seed $943k–$6M; Series A $3.5M–$25M
  • Lead/follow: 54% lead, 46% follow

Portfolio highlights

  • Neuroute —
  • Altis Labs — Altis Labs is the computational imaging company advancing precision medicine. We believe that medical imaging is the richest source of untapped information. Life sciences companies use our software platform, Nota, to accelerate all stages of clinical development. Trained on over 140 million longitudinal real-world images with associated clinicalinformation, our deep learning models predict clinically meaningful outcomes to quantify treatment effect more accurately.
  • VeriSIM Life — Make confident decisions about drug development, quickly and efficiently, using a decision-engine that takes your toughest translational questions and generate actionable insights to guide your next steps.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Milad Alucozai
Angel · San Francisco, California, United States · 1 investments in Spain Life Science startups

Recognized by Business Insider in 2025 as “one of the top 100 early-stage investors,” Dr. Alucozai has experience translating exceptional science and technology into scalable commercial ventures. Alongside his experience as a founder and operator, he has actively invested in over 100 startups across North America and Europe. He has often been thefirst investor to back high-growth companies like Seqera Labs. Milad began his career as a neuroscientist at the intersection of bioengineering, computational biology, and machine learning, where he commercialized platforms designed to deliver promising medicines to patients more efficiently and safely. His focus as an investor has been to accelerate the journey of groundbreaking discoveries from the lab to the market, particularly in the life sciences sector and related computational fields.Milad is a co-founder and General Partner at Pamir Ventures, an early-stage venture firm that invests in technical pioneers developing B2B companies utilizing AI in antiquated industries. He is also a co-founder of Revalia Bio, which aims to establish a human-centric infrastructure for drug discovery and development. By using non-transplantable human organs donated for research, Revalia offers the scientific community unparalleled insights into patient biology, ultimately aiding in the creation of improved treatments and cures. Throughout his operating and investing career, Milad has played a crucial role in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. His previous roles include supporting business development at Accenture, Absci, Bit Bio, Numerate, Mekonos, and AstraZeneca. Through Digitalis Commons, he was an Expert in Residence in support of the Advanced Research Projects Agency for Health (ARPA-H), where he aided the US government and ARPA-H mission to enable transformative biomedical and health breakthroughs, providing health solutions through $1.5 billion in non-dilutive investments. He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a Visiting Scholar appointment at the Wyss Institute at Harvard University.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 54
  • Lead/follow: no public data

Portfolio highlights

  • Replit — Replit is a simple yet powerful online IDE, Editor, Compiler, Interpreter, and REPL. Code, compile, run, and host in 50+ programming languages.
  • Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
  • Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
Show all investments...

Fides Capital
VC Fund · Madrid, Madrid, Spain · 1 investments in Spain Life Science startups

Fides Capital is an investment firm, specialized in seed and early stage technology-based companies with scalable B2B business models that have already achieved recurring income. We back committed and experienced teams who are capable of leading ambitious projects with international projection. But, beyond the professional abilities, for usit's essential to have a personal understanding and alignment of interests with the entrepeneurs in order to row together in the same direction. Partnering with the teams is a key pillar in Fides's investment strategy since we like to collaborate actively with them, sharing our experience and knowledge. We invest between 50,000 € and 400,000 € per deal by disbursing funds in gradual installments and we co-invest with other participants that assume the role of lead investor.Our portfolio companies are mainly in the telecom, B2B services, health, fintech and edutech sectors: - AdmInMe (www.admin-me.com) - Agile Content (www.agilecontent.com) - eGarante: (www.egarante.com) - Excom (www.excom.es) - Imegen (www.imegen.es) - Indexa Capital (www.indexacapital.com) - Joinup (www.joinuptaxi.com) - Kuaderno (www.kuaderno.com) - Masmovil (www.masmovil.es) - Next (www.gruponext.es) - Nuubo (www.nuubo.com) - Playfilm (www.playfilm.tv) - Quantyca (www.quantyca.com)

Show more...

Investment focus

  • Industry: Software, Automotive, Telecommunications
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Spain

Investor stats

  • Total investments: 23
  • Lead/follow: no public data

Portfolio highlights

  • Lawwwing — Lawwwing provides a distinctive solution in the market for website compliance. It's a platform that automatically adapts your website or online store to regulations, keeping it up-to-date and personalized.
  • Rauda AI — Rauda is an artificial intelligence platform specialized in automating customer service with the best customer experience. Take a quantum leap in productivity, reduce costs and improve customer satisfaction with the power of generative artificial intelligence.
  • CHECKTOBUILD — Compare automatically the reality of your construction inspection with the BIM Model and get an accurate as-built analysis.
Show all investments...

BAGi
VC Fund · Girona, Catalonia, Spain · 1 investments in Spain Life Science startups

BAGi is the first business angels network created for invest on Startups with direct impact on Girona's region.

Show more...

Investment focus

  • Industry: Internet, Health Care, Information Technology
  • Stage:Seed, Angel
  • Geography: Spain, Norway, Switzerland

Investor stats

  • Total investments: 8
  • Lead/follow: no public data

Portfolio highlights

  • Aniling — Aniling developing its worldwide patent of the second generation genomic analysis and epigenomic.
  • Petoons Studio — Petoons Studio is a developer of transmedia projects startup.
  • The Smart Lollipop — The Smart Lollipop is a non-intrusive medical device in the shape of a lollipop with the goal to detect diseases with a single saliva sample.
Show all investments...

Alantra
VC Fund · Madrid, Madrid, Spain · 1 investments in Spain Life Science startups

Alantra is an international financial services firm with over 500 professionals across EMEA, the Americas, and Asia.

Show more...

Investment focus

  • Industry: Financial Services, Manufacturing, Information Technology
  • Stage:Private Equity, Debt Financing, Series B
  • Geography: Spain, France, Sweden

Investor stats

  • Total investments: 27
  • Lead/follow: no public data

Portfolio highlights

  • enmacc — enmacc, the OTC energy trading platform, offers innovative solutions for efficient trading of energy commodities in today's dynamic market.
  • SunRoof — Roof of the future
  • Eturnity AG — Die Eturnity Software automatisiert den und erleichtert den Beratungs- und Verkaufsprozess im Bereich der Erneuerbaren Energiesysteme.
Show all investments...

Ship2B Ventures
VC Fund · Barcelona, Catalonia, Spain · 1 investments in Spain Life Science startups

Ship2B Ventures is a venture capital firm that invests in impact startups.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Agriculture
  • Stage:Seed, Series A
  • Geography: Spain, Germany, United Kingdom

Investor stats

  • Total investments: 20
  • Lead/follow: no public data

Portfolio highlights

  • Aortyx — Aortyx is a pioneer company founded by researchers from the IQS School of Engineering and the Hospital Clínic de Barcelona that aims at providing a new generation of endovascular devices to treat vascular diseases. Our technology focuses on tissue regeneration by mimicking the aorta biomechanical environment. It provides a suitable milieu for cellmigration and proliferation in a bioresorbable platform that minimizes differences with the natural dynamics of the aorta.
  • Nido — Heating & cooling accounts for nearly half of all energy consumption and 40% of energy-related carbon dioxide emissions. In the EU 65M+ boilers are over their useful life and 95% of them use fossil fuels and these need urgent change.At Nido, we are streamlining heat pump installation in the residential sector, enabling users to transition toclean heating & cooling faster with affordable pricing. We also support installers get the best out of their time by removing time consuming tasks and allowing them to focus on their preferred task - home installations!
  • Ocean Ecostructures — We convert maritime infrastructures into 'nature positive' spaces through our multi-technological solution.
Show all investments...

Arnaldo Marziali
Angel · Paris, Ile-de-France, France · 1 investments in Spain Life Science startups

Arnaldo Marziali

Show more...

Investment focus

  • Industry: Big Data, Software, Life Science
  • Stage:Pre-Seed
  • Geography: Spain

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Seqera — Seqera Labs is a Barcelona-based business creating solutions for high-performance computing workloads across cloud and clusters. It was founded by the creators of the popular open-source workflow software Nextflow (http://www.nextflow.io).
Show all investments...

General Inception
VC Fund · San Francisco, California, United States · 1 investments in Spain Life Science startups

General Inception partners with inventors to ignite innovation and create transformational companies. We are co-founders bringing together domain expertise, seasoned executive talent, infrastructure resources, and capital to nurture company growth from inception.

Show more...

Investment focus

  • Industry: Biotechnology, Life Science, Genetics
  • Stage:Seed, Pre-Seed
  • Geography: United States, Spain, France

Investor stats

  • Total investments: 6
  • Lead/follow: no public data

Portfolio highlights

  • Biocellis — Biocellis develops ultra-sensitive, bioluminescence-based diagnostics for next-generation immunoassays. Scalable, fast, and point-of-care ready.
  • Pharmacelera — Improving pharmaceutical R+D productivity through a lean drug discovery process based on advanced computational methodologies.
  • Tavira Therapeutics — Tavira Therapeutics develops an innovative technology that equips AAV vectors with molecules to accurately target the intended tissues.
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 1 investments in Spain Life Science startups

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 288
  • Lead/follow: no public data

Portfolio highlights

  • DNA Script — DNA Script is a disruptive DNA synthesis company engineering biology to accelerate breakthroughs in life science and human health. Their revolutionary enzymatic technology powers the world's first benchtop DNA printer, SYNTAX, enabling labs to print their own synthetic oligos for greater workflow control and faster access to results.
  • AAVantgarde Bio — AAVantgarde Bio is developing gene therapies for inherited retinal disorders.
  • Excelsior Sciences — Rebuilding the World, From the Bottom Up
Show all investments...

Pontifax
VC Fund · Herzliya, Tel Aviv, Israel · 1 investments in Spain Life Science startups

Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Israel, France

Investor stats

  • Total investments: 113
  • Round size: Series A $6.3M–$110M; Series B $20M–$128M; Series C $12M–$101M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $14M in 2020

Portfolio highlights

  • ArQule — ArQule, Inc. is a clinical-stage biotechnology company engaged in the research and development of cancer therapeutics. The Company employs technologies, such as its ArQule Kinase Inhibitor Platform (AKIP) to design and develop drugs. The Company's product is ARQ 197, an orally administered inhibitor of the c-Met receptor tyrosine kinase. ARQ197 is being evaluated as monotherapy and in combination therapy in a Phase II clinical development program that includes trials in Microphthalmia Transcription Factor (MiT) associated tumors, non-small cell lung cancer (NSCLC), pancreatic adenocarcinoma and hepatocellular carcinoma (HCC). The Company has licensed commercial rights to ARQ 197 for human cancer indications to Daiichi Sankyo Co., Ltd. (Daiichi Sankyo) in the United States, Europe, South America and the rest of the world, excluding Japan and certain other Asian countries, where it has licensed commercial rights to Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin).
  • Graviton Bioscience — Curing Disease through Restored Homeostasis
  • Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
Show all investments...

Life Science Investor funding in Spain at a glance

Stats across 157 deals from 173 investors.

173
investors
in Spain Life Science startups
157
deals
in Spain Life Science startups
$1.3M
median round
in Spain Life Science startups
50%
lead investors
lead at least one round
26%
Grant
most common funding stage
88/12
VC / Angel
share of investor count

Access all 173 investors in Spain Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science Investors in Spain investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 173 investors investing in Spain Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists